Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Contemporary Clinical Trials Communications
|
July 1, 2024
Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
Catrin Henriksson, Anneli Olsson, Kasper Andersen, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
Philip Leissner, Katarina Mars, Sophia Humphries, et al.
American Heart Journal
|
November 4, 2020
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
Jonatan Wärme, Martin Sundqvist, Katarina Mars, et al.
Circulation
|
September 2, 2020
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
Karolina Szummer, Maria E Montez-Rath, Joakim Alfredsson, et al.
International Journal of Cardiology
|
April 20, 2023
Association of anxiety or depression with risk of recurrent cardiovascular events and death after myocardial infarction: A nationwide registry study
Oskar Flygare, Julia Boberg, Christian Rück, et al.
Frontiers in Physiology
|
January 28, 2021
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the <i>COVID-Omega-F</i> Trial
Hildur Arnardottir, Sven-Christian Pawelzik, Ulf Öhlund Wistbacka, et al.
Resuscitation
|
November 16, 2024
Survival in relation to number of defibrillation attempts in out-of-hospital cardiac arrest
Linn Harrysson, Emma Blick, Akil Awad, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 14, 2019
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial
Pontus Andell, Stefan James, Ollie Östlund, et al.
American Heart Journal
|
March 1, 2014
DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial
Robin Hofmann, Stefan K James, Leif Svensson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 31, 2025
Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction
Anna B C Humphreys, Bertil Lindahl, Anita Berglund, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Contemporary Clinical Trials Communications
|
July 1, 2024
Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
Catrin Henriksson, Anneli Olsson, Kasper Andersen, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
Philip Leissner, Katarina Mars, Sophia Humphries, et al.
American Heart Journal
|
November 4, 2020
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
Jonatan Wärme, Martin Sundqvist, Katarina Mars, et al.
Circulation
|
September 2, 2020
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
Karolina Szummer, Maria E Montez-Rath, Joakim Alfredsson, et al.
International Journal of Cardiology
|
April 20, 2023
Association of anxiety or depression with risk of recurrent cardiovascular events and death after myocardial infarction: A nationwide registry study
Oskar Flygare, Julia Boberg, Christian Rück, et al.
Frontiers in Physiology
|
January 28, 2021
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the <i>COVID-Omega-F</i> Trial
Hildur Arnardottir, Sven-Christian Pawelzik, Ulf Öhlund Wistbacka, et al.
Resuscitation
|
November 16, 2024
Survival in relation to number of defibrillation attempts in out-of-hospital cardiac arrest
Linn Harrysson, Emma Blick, Akil Awad, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 14, 2019
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial
Pontus Andell, Stefan James, Ollie Östlund, et al.
American Heart Journal
|
March 1, 2014
DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial
Robin Hofmann, Stefan K James, Leif Svensson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 31, 2025
Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction
Anna B C Humphreys, Bertil Lindahl, Anita Berglund, et al.
Page
of 8